We perhaps naively thought that the issue of which antiretroviral therapy (ART) to offer 38 million persons living with human immunodeficiency virus (HIV) worldwide was settled for now. Integrase inhibitors had a better side-effect profile and were more potent than similar antiretroviral drugs for…